Addition Therapeutics
The role involves performing and interpreting cell-based and biochemical quality control assays for RNA-based therapeutic materials, maintaining cell lines and reference standards, and analyzing dose-response data to support release and characterization. The position works closely with Process Development and Formulation teams in a fast-paced, science-driven environment.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Addition Therapeutics.
13% above the average for this role
Senior Research Associate*
bighatbiosciences
Research Associate III
WuXi AppTec
Scientist, Analytical Cell Line Engineering & Bioassay Development
BioLife Plasma Services
Senior/Principal Scientist, Cell Based-Potency Assay Development
BioLife Plasma Services
Cell Biologist and Assay Developer
Abiologics
Research Associate III
WuXi AppTec